“Clinical Evaluation of the Significance of FGFR2/3 Genomic Alterations in Urothelial Cancer: A Retrospective Analysis” (2024) Voprosy onkologii, 70(4), pp. 685–695. doi:10.37469/0507-3758-2024-70-4-685-695.